My husband was diagnosed with Alzheimer's after a spinal tap last fall found amyloids in his brain fluid. So he was eligible for Leqembi and began infusions in December. However, after just six infusions over three months, he decided he didn't want to continue. To him, the risks involved seemed to outweigh the very, very slight benefit (perhaps a 5-month slowing of the disease over a couple years). Plus, an MRI is required after every few infusions to make sure there isn't any brain bleeding. Finally, to anyone considering Leqembi, make sure about your insurance coverage first, as it's very expensive. We were lucky because Medicare and our supplemental Blue Cross/Blue Shield covered everything.